PT  - JOURNAL ARTICLE
AU  - Boneparth, Alexis
AU  - Radhakrishna, Suhas M.
AU  - Greenbaum, Larry A.
AU  - Yen, Eric
AU  - Okamura, Daryl M.
AU  - Cooper, Jennifer C.
AU  - Mason, Sherene
AU  - Levy, Deborah M.
AU  - Sule, Sangeeta D.
AU  - Jensen, Paul T.
AU  - Yildirim-Toruner, Cagri
AU  - Ardoin, Stacy P.
AU  - Wenderfer, Scott E.
TI  - Approach to Membranous Lupus Nephritis: A Survey of Pediatric Nephrologists and Pediatric Rheumatologists
AID  - 10.3899/jrheum.170502
DP  - 2017 Sep 15
TA  - The Journal of Rheumatology
PG  - jrheum.170502
4099  - http://www.jrheum.org/content/early/2017/09/11/jrheum.170502.short
4100  - http://www.jrheum.org/content/early/2017/09/11/jrheum.170502.full
AB  - Objective To describe treatment practices for childhood pure membranous lupus nephritis (MLN). Methods Survey study of Childhood Arthritis and Rheumatology Research Alliance and American Society of Pediatric Nephrology members. Results There were 117 respondents who completed the survey (60 pediatric nephrologists, 57 pediatric rheumatologists). Steroids and nonsteroid immunosuppression (NSI) were routinely used by the majority for MLN. Mycophenolate mofetil was the favored initial NSI. Nephrologists used steroids (60% vs 93%) and NSI (53% vs 87%) less often than did rheumatologists for MLN without nephrotic syndrome (NS). Conclusion Pediatric rheumatologists and nephrologists both recommend steroids and NSI for children with MLN, with or without NS.